Global Next Generation Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Next Generation Cancer Diagnostics market size was valued at USD 6377.6 million in 2023 and is forecast to a readjusted size of USD 19960 million by 2030 with a CAGR of 17.7% during review period.
The Global Info Research report includes an overview of the development of the Next Generation Cancer Diagnostics industry chain, the market status of Hospitals (Next Generation Sequencing, qPCR & Multiplexing), Clinics (Next Generation Sequencing, qPCR & Multiplexing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Next Generation Cancer Diagnostics.
Regionally, the report analyzes the Next Generation Cancer Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Next Generation Cancer Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Next Generation Cancer Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Next Generation Cancer Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Next Generation Sequencing, qPCR & Multiplexing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Next Generation Cancer Diagnostics market.
Regional Analysis: The report involves examining the Next Generation Cancer Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Next Generation Cancer Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Next Generation Cancer Diagnostics:
Company Analysis: Report covers individual Next Generation Cancer Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Next Generation Cancer Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Next Generation Cancer Diagnostics. It assesses the current state, advancements, and potential future developments in Next Generation Cancer Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Next Generation Cancer Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Next Generation Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Next Generation Cancer Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next Generation Cancer Diagnostics, with revenue, gross margin and global market share of Next Generation Cancer Diagnostics from 2019 to 2024.
Chapter 3, the Next Generation Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Next Generation Cancer Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Cancer Diagnostics.
Chapter 13, to describe Next Generation Cancer Diagnostics research findings and conclusion.
The Global Info Research report includes an overview of the development of the Next Generation Cancer Diagnostics industry chain, the market status of Hospitals (Next Generation Sequencing, qPCR & Multiplexing), Clinics (Next Generation Sequencing, qPCR & Multiplexing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Next Generation Cancer Diagnostics.
Regionally, the report analyzes the Next Generation Cancer Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Next Generation Cancer Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Next Generation Cancer Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Next Generation Cancer Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Next Generation Sequencing, qPCR & Multiplexing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Next Generation Cancer Diagnostics market.
Regional Analysis: The report involves examining the Next Generation Cancer Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Next Generation Cancer Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Next Generation Cancer Diagnostics:
Company Analysis: Report covers individual Next Generation Cancer Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Next Generation Cancer Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Next Generation Cancer Diagnostics. It assesses the current state, advancements, and potential future developments in Next Generation Cancer Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Next Generation Cancer Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Next Generation Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Next Generation Sequencing
- qPCR & Multiplexing
- DNA Microarrays
- Others
- Hospitals
- Clinics
- Others
- Cepheid
- Koninklijke Philips N.V
- F. Hoffmann-La Roche Ltd
- Qiagen
- Novartis AG
- Abbott
- Thermo Fisher Scientific
- Opko Health
- Myriad Genetics
- Agilent Technologies
- GE Healthcare
- PerkinElmer
- Genomic Health
- Illumina
- Hologic
- Almac Group
- Janssen Global Services
- Sysmex Corporation
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Next Generation Cancer Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next Generation Cancer Diagnostics, with revenue, gross margin and global market share of Next Generation Cancer Diagnostics from 2019 to 2024.
Chapter 3, the Next Generation Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Next Generation Cancer Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Cancer Diagnostics.
Chapter 13, to describe Next Generation Cancer Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Next Generation Cancer Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next Generation Cancer Diagnostics by Type
1.3.1 Overview: Global Next Generation Cancer Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Next Generation Cancer Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Next Generation Sequencing
1.3.4 qPCR & Multiplexing
1.3.5 DNA Microarrays
1.3.6 Others
1.4 Global Next Generation Cancer Diagnostics Market by Application
1.4.1 Overview: Global Next Generation Cancer Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Next Generation Cancer Diagnostics Market Size & Forecast
1.6 Global Next Generation Cancer Diagnostics Market Size and Forecast by Region
1.6.1 Global Next Generation Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Next Generation Cancer Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Cepheid
2.1.1 Cepheid Details
2.1.2 Cepheid Major Business
2.1.3 Cepheid Next Generation Cancer Diagnostics Product and Solutions
2.1.4 Cepheid Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Cepheid Recent Developments and Future Plans
2.2 Koninklijke Philips N.V
2.2.1 Koninklijke Philips N.V Details
2.2.2 Koninklijke Philips N.V Major Business
2.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product and Solutions
2.2.4 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Koninklijke Philips N.V Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd
2.3.1 F. Hoffmann-La Roche Ltd Details
2.3.2 F. Hoffmann-La Roche Ltd Major Business
2.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen Next Generation Cancer Diagnostics Product and Solutions
2.4.4 Qiagen Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Qiagen Recent Developments and Future Plans
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Next Generation Cancer Diagnostics Product and Solutions
2.5.4 Novartis AG Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Novartis AG Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Next Generation Cancer Diagnostics Product and Solutions
2.6.4 Abbott Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product and Solutions
2.7.4 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Opko Health
2.8.1 Opko Health Details
2.8.2 Opko Health Major Business
2.8.3 Opko Health Next Generation Cancer Diagnostics Product and Solutions
2.8.4 Opko Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Opko Health Recent Developments and Future Plans
2.9 Myriad Genetics
2.9.1 Myriad Genetics Details
2.9.2 Myriad Genetics Major Business
2.9.3 Myriad Genetics Next Generation Cancer Diagnostics Product and Solutions
2.9.4 Myriad Genetics Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Myriad Genetics Recent Developments and Future Plans
2.10 Agilent Technologies
2.10.1 Agilent Technologies Details
2.10.2 Agilent Technologies Major Business
2.10.3 Agilent Technologies Next Generation Cancer Diagnostics Product and Solutions
2.10.4 Agilent Technologies Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Agilent Technologies Recent Developments and Future Plans
2.11 GE Healthcare
2.11.1 GE Healthcare Details
2.11.2 GE Healthcare Major Business
2.11.3 GE Healthcare Next Generation Cancer Diagnostics Product and Solutions
2.11.4 GE Healthcare Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GE Healthcare Recent Developments and Future Plans
2.12 PerkinElmer
2.12.1 PerkinElmer Details
2.12.2 PerkinElmer Major Business
2.12.3 PerkinElmer Next Generation Cancer Diagnostics Product and Solutions
2.12.4 PerkinElmer Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 PerkinElmer Recent Developments and Future Plans
2.13 Genomic Health
2.13.1 Genomic Health Details
2.13.2 Genomic Health Major Business
2.13.3 Genomic Health Next Generation Cancer Diagnostics Product and Solutions
2.13.4 Genomic Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Genomic Health Recent Developments and Future Plans
2.14 Illumina
2.14.1 Illumina Details
2.14.2 Illumina Major Business
2.14.3 Illumina Next Generation Cancer Diagnostics Product and Solutions
2.14.4 Illumina Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Illumina Recent Developments and Future Plans
2.15 Hologic
2.15.1 Hologic Details
2.15.2 Hologic Major Business
2.15.3 Hologic Next Generation Cancer Diagnostics Product and Solutions
2.15.4 Hologic Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Hologic Recent Developments and Future Plans
2.16 Almac Group
2.16.1 Almac Group Details
2.16.2 Almac Group Major Business
2.16.3 Almac Group Next Generation Cancer Diagnostics Product and Solutions
2.16.4 Almac Group Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Almac Group Recent Developments and Future Plans
2.17 Janssen Global Services
2.17.1 Janssen Global Services Details
2.17.2 Janssen Global Services Major Business
2.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product and Solutions
2.17.4 Janssen Global Services Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Janssen Global Services Recent Developments and Future Plans
2.18 Sysmex Corporation
2.18.1 Sysmex Corporation Details
2.18.2 Sysmex Corporation Major Business
2.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Product and Solutions
2.18.4 Sysmex Corporation Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Sysmex Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next Generation Cancer Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Next Generation Cancer Diagnostics by Company Revenue
3.2.2 Top 3 Next Generation Cancer Diagnostics Players Market Share in 2023
3.2.3 Top 6 Next Generation Cancer Diagnostics Players Market Share in 2023
3.3 Next Generation Cancer Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Next Generation Cancer Diagnostics Market: Region Footprint
3.3.2 Next Generation Cancer Diagnostics Market: Company Product Type Footprint
3.3.3 Next Generation Cancer Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next Generation Cancer Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Next Generation Cancer Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Next Generation Cancer Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Next Generation Cancer Diagnostics Market Size by Country
6.3.1 North America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Next Generation Cancer Diagnostics Market Size by Country
7.3.1 Europe Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Next Generation Cancer Diagnostics Market Size by Country
9.3.1 South America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Next Generation Cancer Diagnostics Market Drivers
11.2 Next Generation Cancer Diagnostics Market Restraints
11.3 Next Generation Cancer Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Next Generation Cancer Diagnostics Industry Chain
12.2 Next Generation Cancer Diagnostics Upstream Analysis
12.3 Next Generation Cancer Diagnostics Midstream Analysis
12.4 Next Generation Cancer Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Next Generation Cancer Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next Generation Cancer Diagnostics by Type
1.3.1 Overview: Global Next Generation Cancer Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Next Generation Cancer Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Next Generation Sequencing
1.3.4 qPCR & Multiplexing
1.3.5 DNA Microarrays
1.3.6 Others
1.4 Global Next Generation Cancer Diagnostics Market by Application
1.4.1 Overview: Global Next Generation Cancer Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Next Generation Cancer Diagnostics Market Size & Forecast
1.6 Global Next Generation Cancer Diagnostics Market Size and Forecast by Region
1.6.1 Global Next Generation Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Next Generation Cancer Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Next Generation Cancer Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Cepheid
2.1.1 Cepheid Details
2.1.2 Cepheid Major Business
2.1.3 Cepheid Next Generation Cancer Diagnostics Product and Solutions
2.1.4 Cepheid Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Cepheid Recent Developments and Future Plans
2.2 Koninklijke Philips N.V
2.2.1 Koninklijke Philips N.V Details
2.2.2 Koninklijke Philips N.V Major Business
2.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product and Solutions
2.2.4 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Koninklijke Philips N.V Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd
2.3.1 F. Hoffmann-La Roche Ltd Details
2.3.2 F. Hoffmann-La Roche Ltd Major Business
2.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen Next Generation Cancer Diagnostics Product and Solutions
2.4.4 Qiagen Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Qiagen Recent Developments and Future Plans
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Next Generation Cancer Diagnostics Product and Solutions
2.5.4 Novartis AG Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Novartis AG Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Next Generation Cancer Diagnostics Product and Solutions
2.6.4 Abbott Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product and Solutions
2.7.4 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Opko Health
2.8.1 Opko Health Details
2.8.2 Opko Health Major Business
2.8.3 Opko Health Next Generation Cancer Diagnostics Product and Solutions
2.8.4 Opko Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Opko Health Recent Developments and Future Plans
2.9 Myriad Genetics
2.9.1 Myriad Genetics Details
2.9.2 Myriad Genetics Major Business
2.9.3 Myriad Genetics Next Generation Cancer Diagnostics Product and Solutions
2.9.4 Myriad Genetics Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Myriad Genetics Recent Developments and Future Plans
2.10 Agilent Technologies
2.10.1 Agilent Technologies Details
2.10.2 Agilent Technologies Major Business
2.10.3 Agilent Technologies Next Generation Cancer Diagnostics Product and Solutions
2.10.4 Agilent Technologies Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Agilent Technologies Recent Developments and Future Plans
2.11 GE Healthcare
2.11.1 GE Healthcare Details
2.11.2 GE Healthcare Major Business
2.11.3 GE Healthcare Next Generation Cancer Diagnostics Product and Solutions
2.11.4 GE Healthcare Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GE Healthcare Recent Developments and Future Plans
2.12 PerkinElmer
2.12.1 PerkinElmer Details
2.12.2 PerkinElmer Major Business
2.12.3 PerkinElmer Next Generation Cancer Diagnostics Product and Solutions
2.12.4 PerkinElmer Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 PerkinElmer Recent Developments and Future Plans
2.13 Genomic Health
2.13.1 Genomic Health Details
2.13.2 Genomic Health Major Business
2.13.3 Genomic Health Next Generation Cancer Diagnostics Product and Solutions
2.13.4 Genomic Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Genomic Health Recent Developments and Future Plans
2.14 Illumina
2.14.1 Illumina Details
2.14.2 Illumina Major Business
2.14.3 Illumina Next Generation Cancer Diagnostics Product and Solutions
2.14.4 Illumina Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Illumina Recent Developments and Future Plans
2.15 Hologic
2.15.1 Hologic Details
2.15.2 Hologic Major Business
2.15.3 Hologic Next Generation Cancer Diagnostics Product and Solutions
2.15.4 Hologic Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Hologic Recent Developments and Future Plans
2.16 Almac Group
2.16.1 Almac Group Details
2.16.2 Almac Group Major Business
2.16.3 Almac Group Next Generation Cancer Diagnostics Product and Solutions
2.16.4 Almac Group Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Almac Group Recent Developments and Future Plans
2.17 Janssen Global Services
2.17.1 Janssen Global Services Details
2.17.2 Janssen Global Services Major Business
2.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product and Solutions
2.17.4 Janssen Global Services Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Janssen Global Services Recent Developments and Future Plans
2.18 Sysmex Corporation
2.18.1 Sysmex Corporation Details
2.18.2 Sysmex Corporation Major Business
2.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Product and Solutions
2.18.4 Sysmex Corporation Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Sysmex Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next Generation Cancer Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Next Generation Cancer Diagnostics by Company Revenue
3.2.2 Top 3 Next Generation Cancer Diagnostics Players Market Share in 2023
3.2.3 Top 6 Next Generation Cancer Diagnostics Players Market Share in 2023
3.3 Next Generation Cancer Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Next Generation Cancer Diagnostics Market: Region Footprint
3.3.2 Next Generation Cancer Diagnostics Market: Company Product Type Footprint
3.3.3 Next Generation Cancer Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next Generation Cancer Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Next Generation Cancer Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Next Generation Cancer Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Next Generation Cancer Diagnostics Market Size by Country
6.3.1 North America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Next Generation Cancer Diagnostics Market Size by Country
7.3.1 Europe Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Next Generation Cancer Diagnostics Market Size by Country
9.3.1 South America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Next Generation Cancer Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Next Generation Cancer Diagnostics Market Drivers
11.2 Next Generation Cancer Diagnostics Market Restraints
11.3 Next Generation Cancer Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Next Generation Cancer Diagnostics Industry Chain
12.2 Next Generation Cancer Diagnostics Upstream Analysis
12.3 Next Generation Cancer Diagnostics Midstream Analysis
12.4 Next Generation Cancer Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Next Generation Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Next Generation Cancer Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Next Generation Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Next Generation Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Cepheid Company Information, Head Office, and Major Competitors
Table 6. Cepheid Major Business
Table 7. Cepheid Next Generation Cancer Diagnostics Product and Solutions
Table 8. Cepheid Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Cepheid Recent Developments and Future Plans
Table 10. Koninklijke Philips N.V Company Information, Head Office, and Major Competitors
Table 11. Koninklijke Philips N.V Major Business
Table 12. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product and Solutions
Table 13. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Koninklijke Philips N.V Recent Developments and Future Plans
Table 15. F. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
Table 16. F. Hoffmann-La Roche Ltd Major Business
Table 17. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product and Solutions
Table 18. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Table 20. Qiagen Company Information, Head Office, and Major Competitors
Table 21. Qiagen Major Business
Table 22. Qiagen Next Generation Cancer Diagnostics Product and Solutions
Table 23. Qiagen Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Qiagen Recent Developments and Future Plans
Table 25. Novartis AG Company Information, Head Office, and Major Competitors
Table 26. Novartis AG Major Business
Table 27. Novartis AG Next Generation Cancer Diagnostics Product and Solutions
Table 28. Novartis AG Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Novartis AG Recent Developments and Future Plans
Table 30. Abbott Company Information, Head Office, and Major Competitors
Table 31. Abbott Major Business
Table 32. Abbott Next Generation Cancer Diagnostics Product and Solutions
Table 33. Abbott Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Abbott Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product and Solutions
Table 38. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Scientific Recent Developments and Future Plans
Table 40. Opko Health Company Information, Head Office, and Major Competitors
Table 41. Opko Health Major Business
Table 42. Opko Health Next Generation Cancer Diagnostics Product and Solutions
Table 43. Opko Health Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Opko Health Recent Developments and Future Plans
Table 45. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 46. Myriad Genetics Major Business
Table 47. Myriad Genetics Next Generation Cancer Diagnostics Product and Solutions
Table 48. Myriad Genetics Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Myriad Genetics Recent Developments and Future Plans
Table 50. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 51. Agilent Technologies Major Business
Table 52. Agilent Technologies Next Generation Cancer Diagnostics Product and Solutions
Table 53. Agilent Technologies Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Agilent Technologies Recent Developments and Future Plans
Table 55. GE Healthcare Company Information, Head Office, and Major Competitors
Table 56. GE Healthcare Major Business
Table 57. GE Healthcare Next Generation Cancer Diagnostics Product and Solutions
Table 58. GE Healthcare Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. GE Healthcare Recent Developments and Future Plans
Table 60. PerkinElmer Company Information, Head Office, and Major Competitors
Table 61. PerkinElmer Major Business
Table 62. PerkinElmer Next Generation Cancer Diagnostics Product and Solutions
Table 63. PerkinElmer Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. PerkinElmer Recent Developments and Future Plans
Table 65. Genomic Health Company Information, Head Office, and Major Competitors
Table 66. Genomic Health Major Business
Table 67. Genomic Health Next Generation Cancer Diagnostics Product and Solutions
Table 68. Genomic Health Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Genomic Health Recent Developments and Future Plans
Table 70. Illumina Company Information, Head Office, and Major Competitors
Table 71. Illumina Major Business
Table 72. Illumina Next Generation Cancer Diagnostics Product and Solutions
Table 73. Illumina Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Illumina Recent Developments and Future Plans
Table 75. Hologic Company Information, Head Office, and Major Competitors
Table 76. Hologic Major Business
Table 77. Hologic Next Generation Cancer Diagnostics Product and Solutions
Table 78. Hologic Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Hologic Recent Developments and Future Plans
Table 80. Almac Group Company Information, Head Office, and Major Competitors
Table 81. Almac Group Major Business
Table 82. Almac Group Next Generation Cancer Diagnostics Product and Solutions
Table 83. Almac Group Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Almac Group Recent Developments and Future Plans
Table 85. Janssen Global Services Company Information, Head Office, and Major Competitors
Table 86. Janssen Global Services Major Business
Table 87. Janssen Global Services Next Generation Cancer Diagnostics Product and Solutions
Table 88. Janssen Global Services Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Janssen Global Services Recent Developments and Future Plans
Table 90. Sysmex Corporation Company Information, Head Office, and Major Competitors
Table 91. Sysmex Corporation Major Business
Table 92. Sysmex Corporation Next Generation Cancer Diagnostics Product and Solutions
Table 93. Sysmex Corporation Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Sysmex Corporation Recent Developments and Future Plans
Table 95. Global Next Generation Cancer Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 96. Global Next Generation Cancer Diagnostics Revenue Share by Players (2019-2024)
Table 97. Breakdown of Next Generation Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Next Generation Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Next Generation Cancer Diagnostics Players
Table 100. Next Generation Cancer Diagnostics Market: Company Product Type Footprint
Table 101. Next Generation Cancer Diagnostics Market: Company Product Application Footprint
Table 102. Next Generation Cancer Diagnostics New Market Entrants and Barriers to Market Entry
Table 103. Next Generation Cancer Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Next Generation Cancer Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Next Generation Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Table 106. Global Next Generation Cancer Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 107. Global Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024)
Table 108. Global Next Generation Cancer Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 109. North America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Next Generation Cancer Diagnostics Raw Material
Table 140. Key Suppliers of Next Generation Cancer Diagnostics Raw Materials
Table 1. Global Next Generation Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Next Generation Cancer Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Next Generation Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Next Generation Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Cepheid Company Information, Head Office, and Major Competitors
Table 6. Cepheid Major Business
Table 7. Cepheid Next Generation Cancer Diagnostics Product and Solutions
Table 8. Cepheid Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Cepheid Recent Developments and Future Plans
Table 10. Koninklijke Philips N.V Company Information, Head Office, and Major Competitors
Table 11. Koninklijke Philips N.V Major Business
Table 12. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product and Solutions
Table 13. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Koninklijke Philips N.V Recent Developments and Future Plans
Table 15. F. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
Table 16. F. Hoffmann-La Roche Ltd Major Business
Table 17. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product and Solutions
Table 18. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Table 20. Qiagen Company Information, Head Office, and Major Competitors
Table 21. Qiagen Major Business
Table 22. Qiagen Next Generation Cancer Diagnostics Product and Solutions
Table 23. Qiagen Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Qiagen Recent Developments and Future Plans
Table 25. Novartis AG Company Information, Head Office, and Major Competitors
Table 26. Novartis AG Major Business
Table 27. Novartis AG Next Generation Cancer Diagnostics Product and Solutions
Table 28. Novartis AG Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Novartis AG Recent Developments and Future Plans
Table 30. Abbott Company Information, Head Office, and Major Competitors
Table 31. Abbott Major Business
Table 32. Abbott Next Generation Cancer Diagnostics Product and Solutions
Table 33. Abbott Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Abbott Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product and Solutions
Table 38. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Scientific Recent Developments and Future Plans
Table 40. Opko Health Company Information, Head Office, and Major Competitors
Table 41. Opko Health Major Business
Table 42. Opko Health Next Generation Cancer Diagnostics Product and Solutions
Table 43. Opko Health Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Opko Health Recent Developments and Future Plans
Table 45. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 46. Myriad Genetics Major Business
Table 47. Myriad Genetics Next Generation Cancer Diagnostics Product and Solutions
Table 48. Myriad Genetics Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Myriad Genetics Recent Developments and Future Plans
Table 50. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 51. Agilent Technologies Major Business
Table 52. Agilent Technologies Next Generation Cancer Diagnostics Product and Solutions
Table 53. Agilent Technologies Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Agilent Technologies Recent Developments and Future Plans
Table 55. GE Healthcare Company Information, Head Office, and Major Competitors
Table 56. GE Healthcare Major Business
Table 57. GE Healthcare Next Generation Cancer Diagnostics Product and Solutions
Table 58. GE Healthcare Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. GE Healthcare Recent Developments and Future Plans
Table 60. PerkinElmer Company Information, Head Office, and Major Competitors
Table 61. PerkinElmer Major Business
Table 62. PerkinElmer Next Generation Cancer Diagnostics Product and Solutions
Table 63. PerkinElmer Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. PerkinElmer Recent Developments and Future Plans
Table 65. Genomic Health Company Information, Head Office, and Major Competitors
Table 66. Genomic Health Major Business
Table 67. Genomic Health Next Generation Cancer Diagnostics Product and Solutions
Table 68. Genomic Health Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Genomic Health Recent Developments and Future Plans
Table 70. Illumina Company Information, Head Office, and Major Competitors
Table 71. Illumina Major Business
Table 72. Illumina Next Generation Cancer Diagnostics Product and Solutions
Table 73. Illumina Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Illumina Recent Developments and Future Plans
Table 75. Hologic Company Information, Head Office, and Major Competitors
Table 76. Hologic Major Business
Table 77. Hologic Next Generation Cancer Diagnostics Product and Solutions
Table 78. Hologic Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Hologic Recent Developments and Future Plans
Table 80. Almac Group Company Information, Head Office, and Major Competitors
Table 81. Almac Group Major Business
Table 82. Almac Group Next Generation Cancer Diagnostics Product and Solutions
Table 83. Almac Group Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Almac Group Recent Developments and Future Plans
Table 85. Janssen Global Services Company Information, Head Office, and Major Competitors
Table 86. Janssen Global Services Major Business
Table 87. Janssen Global Services Next Generation Cancer Diagnostics Product and Solutions
Table 88. Janssen Global Services Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Janssen Global Services Recent Developments and Future Plans
Table 90. Sysmex Corporation Company Information, Head Office, and Major Competitors
Table 91. Sysmex Corporation Major Business
Table 92. Sysmex Corporation Next Generation Cancer Diagnostics Product and Solutions
Table 93. Sysmex Corporation Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Sysmex Corporation Recent Developments and Future Plans
Table 95. Global Next Generation Cancer Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 96. Global Next Generation Cancer Diagnostics Revenue Share by Players (2019-2024)
Table 97. Breakdown of Next Generation Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Next Generation Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Next Generation Cancer Diagnostics Players
Table 100. Next Generation Cancer Diagnostics Market: Company Product Type Footprint
Table 101. Next Generation Cancer Diagnostics Market: Company Product Application Footprint
Table 102. Next Generation Cancer Diagnostics New Market Entrants and Barriers to Market Entry
Table 103. Next Generation Cancer Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Next Generation Cancer Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Next Generation Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Table 106. Global Next Generation Cancer Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 107. Global Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024)
Table 108. Global Next Generation Cancer Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 109. North America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Next Generation Cancer Diagnostics Raw Material
Table 140. Key Suppliers of Next Generation Cancer Diagnostics Raw Materials
LIST OF FIGURES
Figure 1. Next Generation Cancer Diagnostics Picture
Figure 2. Global Next Generation Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Next Generation Cancer Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Next Generation Sequencing
Figure 5. qPCR & Multiplexing
Figure 6. DNA Microarrays
Figure 7. Others
Figure 8. Global Next Generation Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Next Generation Cancer Diagnostics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Next Generation Cancer Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Next Generation Cancer Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Next Generation Cancer Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Next Generation Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Next Generation Cancer Diagnostics Consumption Value Market Share by Region in 2023
Figure 18. North America Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Next Generation Cancer Diagnostics Revenue Share by Players in 2023
Figure 24. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Next Generation Cancer Diagnostics Market Share in 2023
Figure 26. Global Top 6 Players Next Generation Cancer Diagnostics Market Share in 2023
Figure 27. Global Next Generation Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Figure 28. Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2025-2030)
Figure 29. Global Next Generation Cancer Diagnostics Consumption Value Share by Application (2019-2024)
Figure 30. Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2025-2030)
Figure 31. North America Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 65. Next Generation Cancer Diagnostics Market Drivers
Figure 66. Next Generation Cancer Diagnostics Market Restraints
Figure 67. Next Generation Cancer Diagnostics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostics in 2023
Figure 70. Manufacturing Process Analysis of Next Generation Cancer Diagnostics
Figure 71. Next Generation Cancer Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Next Generation Cancer Diagnostics Picture
Figure 2. Global Next Generation Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Next Generation Cancer Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Next Generation Sequencing
Figure 5. qPCR & Multiplexing
Figure 6. DNA Microarrays
Figure 7. Others
Figure 8. Global Next Generation Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Next Generation Cancer Diagnostics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Next Generation Cancer Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Next Generation Cancer Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Next Generation Cancer Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Next Generation Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Next Generation Cancer Diagnostics Consumption Value Market Share by Region in 2023
Figure 18. North America Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Next Generation Cancer Diagnostics Revenue Share by Players in 2023
Figure 24. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Next Generation Cancer Diagnostics Market Share in 2023
Figure 26. Global Top 6 Players Next Generation Cancer Diagnostics Market Share in 2023
Figure 27. Global Next Generation Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Figure 28. Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2025-2030)
Figure 29. Global Next Generation Cancer Diagnostics Consumption Value Share by Application (2019-2024)
Figure 30. Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2025-2030)
Figure 31. North America Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Next Generation Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Next Generation Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Next Generation Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 65. Next Generation Cancer Diagnostics Market Drivers
Figure 66. Next Generation Cancer Diagnostics Market Restraints
Figure 67. Next Generation Cancer Diagnostics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostics in 2023
Figure 70. Manufacturing Process Analysis of Next Generation Cancer Diagnostics
Figure 71. Next Generation Cancer Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
